Table 4 DNA (%) presented in “head” and “ tail ” pre- and post-incubation with doxorubicin in breast cancer cell lines
Control | Doxorubicin (1 μM) | |||
|---|---|---|---|---|
% DNA | % DNA | % DNA | % DNA | |
(mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | (mean ± 1.96 S.E.) | |
in Head | in Tail | in Head | in Tail | |
MCF-7 | 66.43 ± 3.68 | 33.56 ± 3.68 | 81.33 ± 2.67 | 19.17 ± 2.62 |
MDA-MB 231 | 77.14 ± 2.98 | 22.85 ± 2.98 | 83.93 ± 1.94 | 16.06 ± 1.94 |
T47D | 77.87 ± 2.60 | 22.12 ± 2.60 | 83.17 ± 2.27 | 16.82 ± 2.27 |